Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NAMIC ClearaCIL Contrast Injection Lines

K-Number: K163141 · 2017-01-06

Decision Date2017-01-06
Product CodeDQO
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

NAMIC ClearaCIL Contrast Injection Lines is a medical device manufactured by AngioDynamics, Inc.. It received FDA 510(k) clearance on 2017-01-06 under approval number K163141. The device is classified under product code DQO. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NAMIC ClearaCIL Contrast Injection Lines?

NAMIC ClearaCIL Contrast Injection Lines is a medical device that received FDA 510(k) clearance on 2017-01-06. It is manufactured by AngioDynamics, Inc.. The 510(k) number is K163141.

When was NAMIC ClearaCIL Contrast Injection Lines approved by the FDA?

NAMIC ClearaCIL Contrast Injection Lines received FDA 510(k) clearance on 2017-01-06, under approval number K163141.

What company makes NAMIC ClearaCIL Contrast Injection Lines?

NAMIC ClearaCIL Contrast Injection Lines is manufactured by AngioDynamics, Inc..

What is the FDA product code for NAMIC ClearaCIL Contrast Injection Lines?

The FDA product code for NAMIC ClearaCIL Contrast Injection Lines is DQO.

Related Clinical Trials

Other Devices by AngioDynamics, Inc.

View all 28 devices →

Related Devices (Code: DQO)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.